Home > Insider Trading > Filing (0000899243-22-015653)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1840904	Atai Life Sciences N.v.	ATAI	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1845711	Ltd. Group Investment Apeiron	66 &Amp; 67, Beatrice, Amery Street Sliema O1 SLM1707		No	No	Yes	No
1845872	Christian Angermayer	66 &Amp; 67, Beatrice, Amery Street Sliema O1 SLM1707		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares	Acquisiton	2022-04-22	52,820	$4.83	1,667,731	No	4	P	Indirect	By Apeiron Presight Capital Fund II, L.P.
Common Shares	Acquisiton	2022-04-25	8,961	$4.78	1,676,692	No	4	P	Indirect	By Apeiron Presight Capital Fund II, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Apeiron Presight Capital Fund II, L.P.
No	4	P	Indirect	By Apeiron Presight Capital Fund II, L.P.

Footnotes

The price reported in Column 4 is a weighted average price. The common shares were purchased in multiple transactions at prices ranging from $4.77 to $4.90 per share. The reporting persons undertake to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The common shares were purchased in multiple transactions at prices ranging from $4.72 to $4.80 per share. The reporting persons undertake to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.